Commercially available tests to identify Candida auris susceptibility perform poorly

FHS
June 18, 2023
3:53 pm

Matching an infection with Candida auris, a pathogenic yeast, to an effective antifungal is a critical clinical decision.

COVID-19 infection linked to increased risk of high blood pressure

An analysis of electronic medical records for more than 45,000 people found that COVID-19 infection was significantly associated with the development of high blood pressure,

August 21, 2023

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease modeling in the field of neuroscience research.

January 11, 2024

Revance to be acquired for $900M+ as Botox trade secrets lawsuit continues

Revance Therapeutics, the maker of Botox competitor Daxxify, will be acquired for more than $900 million. Crown Laboratories will buy out … Sign up to

August 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.